The Department of Health and Human Services (HHS) is re-launching a task force focused on the safety of childhood vaccines. | ...

With its domination of the indication- and brand-specific analyses, it should come as no surprise that AstraZeneca led the ...

As President Donald Trump works to move sky-high U.S. drug prices closer to those in other developed countries, Eli Lilly ...

San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves ...

President Donald Trump’s announcement about tariffs on pharmaceutical goods imported to the United States is delayed. | ...

Sana Biotechnology, which had planned to produce drugs in-house, will instead turn to CDMOs for manufacturing and pause the ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...

As it continues development of its rademikibart for asthma and other inflammatory diseases, Connect Biopharma is teaming up ...

Roughly three months after signing an executive order to streamline the | President Donald Trump has inked a new executive order calling on the HHS’ Administration for Strategic Preparedness and ...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

The China-based phase 3 trial of telitacicept in primary Sjögren's syndrome (pSS) met its primary endpoint, which focused on ...